{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:40:13Z","timestamp":1740123613465,"version":"3.37.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,11,14]],"date-time":"2016-11-14T00:00:00Z","timestamp":1479081600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","award":["KOF Mandate"],"award-info":[{"award-number":["KOF Mandate"]}],"id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001245","name":"Jeffrey Modell Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001245","id-type":"DOI","asserted-by":"publisher"}]},{"name":"FWO Vlaanderen","award":["None"],"award-info":[{"award-number":["None"]}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s10875-016-0351-9","type":"journal-article","created":{"date-parts":[[2016,11,14]],"date-time":"2016-11-14T07:37:31Z","timestamp":1479109051000},"page":"12-17","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["AD Hyper-IgE Syndrome Due to a Novel Loss-of-Function Mutation in STAT3: a Diagnostic Pursuit Won by Clinical Acuity"],"prefix":"10.1007","volume":"37","author":[{"given":"Leen","family":"Moens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi","family":"Schaballie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnout","family":"Voet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Bossuyt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Laurent","family":"Casanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Boisson-Dupuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart G.","family":"Tangye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Meyts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,14]]},"reference":[{"issue":"16","key":"351_CR1","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJMoa073687","volume":"357","author":"SM Holland","year":"2007","unstructured":"Holland SM, DeLeo FR, Elloumi HZ, Hsu AP, Uzel G, Brodsky N, et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med. 2007;357(16):1608\u201319.","journal-title":"N Engl J Med"},{"issue":"7157","key":"351_CR2","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/nature06096","volume":"448","author":"Y Minegishi","year":"2007","unstructured":"Minegishi Y, Saito M, Tsuchiya S, Tsuge I, Takada H, Hara T, et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature. 2007;448(7157):1058\u201362.","journal-title":"Nature"},{"issue":"7","key":"351_CR3","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10875-015-0187-8","volume":"35","author":"TP Vogel","year":"2015","unstructured":"Vogel TP, Milner JD, Cooper MA. The ying and yang of STAT3 in human disease. J Clin Immunol. 2015;35(7):615\u201323.","journal-title":"J Clin Immunol"},{"issue":"2","key":"351_CR4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/pai.12512","volume":"27","author":"B Hagl","year":"2016","unstructured":"Hagl B, Heinz V, Schlesinger A, Spielberger BD, Sawalle-Belohradsky J, Senn-Rauh M, et al. Key findings to expedite the diagnosis of hyper-IgE syndromes in infants and young children. Pediatr Allergy Immunol. 2016;27(2):177\u201384.","journal-title":"Pediatr Allergy Immunol"},{"issue":"3","key":"351_CR5","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jaci.2010.06.029","volume":"126","author":"LF Schimke","year":"2010","unstructured":"Schimke LF, Sawalle-Belohradsky J, Roesler J, Wollenberg A, Rack A, Borte M, et al. Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis. J Allergy Clin Immunol. 2010;126(3):611\u20137 e1.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"351_CR6","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jaci.2009.10.059","volume":"125","author":"C Woellner","year":"2010","unstructured":"Woellner C, Gertz EM, Schaffer AA, Lagos M, Perro M, Glocker EO, et al. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. J Allergy Clin Immunol. 2010;125(2):424\u201332 e8.","journal-title":"J Allergy Clin Immunol"},{"issue":"17","key":"351_CR7","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1182\/blood-2011-11-392985","volume":"119","author":"CS Ma","year":"2012","unstructured":"Ma CS, Avery DT, Chan A, Batten M, Bustamante J, Boisson-Dupuis S, et al. Functional STAT3 deficiency compromises the generation of human T follicular helper cells. Blood. 2012;119(17):3997\u20134008.","journal-title":"Blood"},{"issue":"16","key":"351_CR8","first-page":"30437","volume":"S0091\u20136749","author":"A Kane","year":"2016","unstructured":"Kane A, Lau A, Brink R, Tangye SG, Deenick EK. B-cell-specific STAT3 deficiency: Insight into the molecular basis of autosomal-dominant hyper-IgE syndrome. J Allergy Clin Immunol. 2016;S0091\u20136749(16):30437\u20137.","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"351_CR9","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s10875-015-0205-x","volume":"35","author":"G Frans","year":"2015","unstructured":"Frans G, Moens L, Schrijvers R, Wuyts G, Bouckaert B, Schaballie H, et al. PID in disguise: molecular diagnosis of IRAK-4 deficiency in an adult previously misdiagnosed with autosomal dominant hyper IgE syndrome. J Clin Immunol. 2015;35(8):739\u201344.","journal-title":"J Clin Immunol"},{"issue":"4","key":"351_CR10","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/MD.0b013e31825f95b9","volume":"91","author":"MO Chandesris","year":"2012","unstructured":"Chandesris MO, Melki I, Natividad A, Puel A, Fieschi C, Yun L, et al. Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey. Medicine (Baltimore). 2012;91(4):e1\u2013e19.","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"351_CR11","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1084\/jem.20080218","volume":"205","author":"CS Ma","year":"2008","unstructured":"Ma CS, Chew GY, Simpson N, Priyadarshi A, Wong M, Grimbacher B, et al. Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3. J Exp Med. 2008;205(7):1551\u20137.","journal-title":"J Exp Med"},{"issue":"5","key":"351_CR12","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1084\/jem.20141065","volume":"212","author":"Y Ling","year":"2015","unstructured":"Ling Y, Cypowyj S, Aytekin C, Galicchio M, Camcioglu Y, Nepesov S, et al. Inherited IL-17RC deficiency in patients with chronic mucocutaneous candidiasis. J Exp Med. 2015;212(5):619\u201331.","journal-title":"J Exp Med"},{"issue":"4","key":"351_CR13","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.immuni.2013.09.002","volume":"39","author":"B Boisson","year":"2013","unstructured":"Boisson B, Wang C, Pedergnana V, Wu L, Cypowyj S, Rybojad M, et al. An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis. Immunity. 2013;39(4):676\u201386.","journal-title":"Immunity"},{"issue":"6248","key":"351_CR14","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1126\/science.aaa4282","volume":"349","author":"S Okada","year":"2015","unstructured":"Okada S, Markle JG, Deenick EK, Mele F, Averbuch D, Lagos M, et al. Immunodeficiencies. Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations. Science. 2015;349(6248):606\u201313.","journal-title":"Science"},{"issue":"8","key":"351_CR15","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1084\/jem.20110958","volume":"208","author":"L Liu","year":"2011","unstructured":"Liu L, Okada S, Kong XF, Kreins AY, Cypowyj S, Abhyankar A, et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med. 2011;208(8):1635\u201348.","journal-title":"J Exp Med"},{"issue":"5","key":"351_CR16","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jaci.2012.09.011","volume":"130","author":"L Marodi","year":"2012","unstructured":"Marodi L, Cypowyj S, Toth B, Chernyshova L, Puel A, Casanova JL. Molecular mechanisms of mucocutaneous immunity against Candida and Staphylococcus species. J Allergy Clin Immunol. 2012;130(5):1019\u201327.","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"351_CR17","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1084\/jem.20151467","volume":"213","author":"CS Ma","year":"2016","unstructured":"Ma CS, Wong N, Rao G, Nguyen A, Avery DT, Payne K, et al. Unique and shared signaling pathways cooperate to regulate the differentiation of human CD4+ T cells into distinct effector subsets. J Exp Med. 2016;213(8):1589\u2013608.","journal-title":"J Exp Med"},{"issue":"6","key":"351_CR18","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1084\/jem.20141992","volume":"212","author":"RP Wilson","year":"2015","unstructured":"Wilson RP, Ives ML, Rao G, Lau A, Payne K, Kobayashi M, et al. STAT3 is a critical cell-intrinsic regulator of human unconventional T cell numbers and function. J Exp Med. 2015;212(6):855\u201364.","journal-title":"J Exp Med"},{"issue":"7","key":"351_CR19","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.febslet.2013.01.065","volume":"587","author":"E Nkansah","year":"2013","unstructured":"Nkansah E, Shah R, Collie GW, Parkinson GN, Palmer J, Rahman KM, et al. Observation of unphosphorylated STAT3 core protein binding to target dsDNA by PEMSA and X-ray crystallography. FEBS Lett. 2013;587(7):833\u20139.","journal-title":"FEBS Lett"},{"issue":"1","key":"351_CR20","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.molimm.2008.07.001","volume":"46","author":"H Jiao","year":"2008","unstructured":"Jiao H, Toth B, Erdos M, Fransson I, Rakoczi E, Balogh I, et al. Novel and recurrent STAT3 mutations in hyper-IgE syndrome patients from different ethnic groups. Mol Immunol. 2008;46(1):202\u20136.","journal-title":"Mol Immunol"},{"issue":"5","key":"351_CR21","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00125817-199907000-00008","volume":"1","author":"B Grimbacher","year":"1999","unstructured":"Grimbacher B, Dutra AS, Holland SM, Fischer RE, Pao M, Gallin JI, et al. Analphoid marker chromosome in a patient with hyper-IgE syndrome, autism, and mild mental retardation. Genet Med. 1999;1(5):213\u20138.","journal-title":"Genet Med"},{"issue":"11","key":"351_CR22","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1182\/blood-2015-09-669937","volume":"127","author":"MW Wlodarski","year":"2016","unstructured":"Wlodarski MW, Hirabayashi S, Pastor V, Stary J, Hasle H, Masetti R, et al. Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents. Blood. 2016;127(11):1387\u201397.","journal-title":"Blood"},{"issue":"1","key":"351_CR23","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.clim.2008.11.002","volume":"131","author":"LR Shiow","year":"2009","unstructured":"Shiow LR, Paris K, Akana MC, Cyster JG, Sorensen RU, Puck JM. Severe combined immunodeficiency (SCID) and attention deficit hyperactivity disorder (ADHD) associated with a Coronin-1A mutation and a chromosome 16p11.2 deletion. Clin Immunol. 2009;131(1):24\u201330.","journal-title":"Clin Immunol"},{"issue":"8","key":"351_CR24","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/DBP.0000000000000210","volume":"36","author":"KL Tang","year":"2015","unstructured":"Tang KL, Antshel KM, Fremont WP, Kates WR. Behavioral and psychiatric phenotypes in 22q11.2 deletion syndrome. J Dev Behav Pediatr. 2015;36(8):639\u201350.","journal-title":"J Dev Behav Pediatr"},{"issue":"11","key":"351_CR25","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/ni.3298","volume":"16","author":"DI Godfrey","year":"2015","unstructured":"Godfrey DI, Uldrich AP, McCluskey J, Rossjohn J, Moody DB. The burgeoning family of unconventional T cells. Nat Immunol. 2015;16(11):1114\u201323.","journal-title":"Nat Immunol"},{"issue":"12","key":"351_CR26","doi-asserted-by":"crossref","first-page":"5953","DOI":"10.4049\/jimmunol.1403066","volume":"194","author":"CO Maher","year":"2015","unstructured":"Maher CO, Dunne K, Comerford R, O\u2019Dea S, Loy A, Woo J, et al. Candida albicans stimulates IL-23 release by human dendritic cells and downstream IL-17 secretion by Vdelta1 T cells. J Immunol. 2015;194(12):5953\u201360.","journal-title":"J Immunol"},{"issue":"26","key":"351_CR27","doi-asserted-by":"crossref","first-page":"6611","DOI":"10.1182\/blood-2009-01-198028","volume":"113","author":"D Fenoglio","year":"2009","unstructured":"Fenoglio D, Poggi A, Catellani S, Battaglia F, Ferrera A, Setti M, et al. Vdelta1 T lymphocytes producing IFN-gamma and IL-17 are expanded in HIV-1-infected patients and respond to Candida albicans. Blood. 2009;113(26):6611\u20138.","journal-title":"Blood"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-016-0351-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-016-0351-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-016-0351-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T23:31:33Z","timestamp":1498347093000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-016-0351-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,14]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["351"],"URL":"https:\/\/doi.org\/10.1007\/s10875-016-0351-9","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"type":"print","value":"0271-9142"},{"type":"electronic","value":"1573-2592"}],"subject":[],"published":{"date-parts":[[2016,11,14]]}}}